Danske Bank A/s »

Biosante Pharmaceuticals shares owned by Danske Bank A/s

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Danske Bank A/s from 13F filings

Historical chart of Danske Bank A/s investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Danske Bank A/s consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Danske Bank A/s

Quarter filed Position value Share count Share price at filing
2025-12-31 $16k 200 78.94
2025-09-30 $864k 9.4k 91.60
2025-06-30 $1.1M 17k 65.25
2025-03-31 $1.9M 28k 66.95

More positions owned by Danske Bank A/s

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Johnson & Johnson (JNJ)
Berkshire Hathaway Cl B New (BRK.B)
Wal-Mart Stores (WMT)

View all positions for Danske Bank A/s

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
State Street Corporation
Citadel Advisors
Global Alpha Capital Management
Dimensional Fund Advisors
Soleus Capital Management
Tang Capital Management
Deep Track Capital
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Deutsche Bank Aktiengesellschaft
Nuveen
Ranger Investment Management

View all funds holding Biosante Pharmaceuticals